These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32100477)

  • 1. Evidence and indications for systemic treatment in diabetic retinopathy: a systematic review.
    Elkjaer AS; Lynge SK; Grauslund J
    Acta Ophthalmol; 2020 Jun; 98(4):329-336. PubMed ID: 32100477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of diabetic retinopathy: a systematic review.
    Mohamed Q; Gillies MC; Wong TY
    JAMA; 2007 Aug; 298(8):902-16. PubMed ID: 17712074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and treatment of diabetic retinopathy: evidence from large, randomized trials. The emerging role of fenofibrate.
    Simó R; Hernández C
    Rev Recent Clin Trials; 2012 Feb; 7(1):71-80. PubMed ID: 21864248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost Effectiveness of Treatments for Diabetic Retinopathy: A Systematic Literature Review.
    Maniadakis N; Konstantakopoulou E
    Pharmacoeconomics; 2019 Aug; 37(8):995-1010. PubMed ID: 31012025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenofibrate - a potential systemic treatment for diabetic retinopathy?
    Wong TY; Simó R; Mitchell P
    Am J Ophthalmol; 2012 Jul; 154(1):6-12. PubMed ID: 22709833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenofibrate: a new treatment for diabetic retinopathy. Molecular mechanisms and future perspectives.
    Simó R; Roy S; Behar-Cohen F; Keech A; Mitchell P; Wong TY
    Curr Med Chem; 2013; 20(26):3258-66. PubMed ID: 23745548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.
    Keech AC; Mitchell P; Summanen PA; O'Day J; Davis TM; Moffitt MS; Taskinen MR; Simes RJ; Tse D; Williamson E; Merrifield A; Laatikainen LT; d'Emden MC; Crimet DC; O'Connell RL; Colman PG;
    Lancet; 2007 Nov; 370(9600):1687-97. PubMed ID: 17988728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
    Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N
    Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current trends in the pharmacotherapy of diabetic retinopathy.
    Kumar B; Gupta SK; Saxena R; Srivastava S
    J Postgrad Med; 2012; 58(2):132-9. PubMed ID: 22718058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Effects of Intravitreal 0.19 mg Fluocinolone Acetonide Implant on Progression and Regression of Diabetic Retinopathy.
    Wykoff CC; Chakravarthy U; Campochiaro PA; Bailey C; Green K; Cunha-Vaz J
    Ophthalmology; 2017 Apr; 124(4):440-449. PubMed ID: 28081945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-Lowering Medications Are Associated with Lower Risk of Retinopathy and Ophthalmic Interventions among United States Patients with Diabetes.
    Vail D; Callaway NF; Ludwig CA; Saroj N; Moshfeghi DM
    Am J Ophthalmol; 2019 Nov; 207():378-384. PubMed ID: 31194953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-lowering medication is associated with decreased risk of diabetic retinopathy and the need for treatment in patients with type 2 diabetes: A real-world observational analysis of a health claims database.
    Kawasaki R; Konta T; Nishida K
    Diabetes Obes Metab; 2018 Oct; 20(10):2351-2360. PubMed ID: 29790265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins and Fibrates for Diabetic Retinopathy: Protocol for a Systematic Review.
    Mozetic V; Freitas CG; Riera R
    JMIR Res Protoc; 2017 Feb; 6(2):e30. PubMed ID: 28228373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the treatment of diabetic retinopathy.
    Yam JC; Kwok AK
    Hong Kong Med J; 2007 Feb; 13(1):46-60. PubMed ID: 17277392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Fenofibrate and Diabetic Retinopathy in Type 2 Diabetic Patients: A Population-Based Retrospective Cohort Study in Taiwan.
    Lin YC; Chen YC; Horng JT; Chen JM
    Medicina (Kaunas); 2020 Jul; 56(8):. PubMed ID: 32751875
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical treatment of diabetic retinopathy: a systematic review.
    Thagaard MS; Vergmann AS; Grauslund J
    Acta Ophthalmol; 2022 Mar; 100(2):136-147. PubMed ID: 34096180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review on urine albumin testing for early detection of diabetic complications.
    Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C
    Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes.
    Noonan JE; Jenkins AJ; Ma JX; Keech AC; Wang JJ; Lamoureux EL
    Diabetes; 2013 Dec; 62(12):3968-75. PubMed ID: 24264394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for Diabetic Retinopathy in Type 1 Diabetes: Systematic Review and Meta-Analysis.
    Virk SA; Donaghue KC; Wong TY; Craig ME
    Am J Ophthalmol; 2015 Nov; 160(5):1055-1064.e4. PubMed ID: 26210869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-Based Treatment of Diabetic Retinopathy.
    El Rami H; Barham R; Sun JK; Silva PS
    Semin Ophthalmol; 2017; 32(1):67-74. PubMed ID: 27700224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.